Mitochondrial‑Nuclear Coupling as a Latent Alignment Signal for Multi‑Omics Biological Age Estimation

Hypothesis

We hypothesize that incorporating mitochondrial retrograde signaling as a coupling constraint improves the alignment of genomic, epigenomic, transcriptomic, proteomic, and metabolomic manifolds onto a shared biological age latent space, leading to better prediction of functional aging outcomes than current multi‑omics clocks that rely on colocalization or post‑hoc integration.

Mechanistic Basis

Mitochondria emit metabolites, reactive oxygen species, and NAD+‐dependent signals that modify nuclear chromatin and alter transcriptional programs. These signals change with age and create coordinated shifts across omics layers. If a latent model ignores this bidirectional communication, each modality may be forced into a space that reflects technical noise rather than true physiological coupling. By adding a loss term that maximizes mutual information between mitochondrial‑derived features (e.g., circulating cell‑free DNA, plasma metabolomics of TCA intermediates) and the shared latent representation, we encourage the network to learn a manifold where age‑related drift is concordant across layers.

This idea extends the observation that true manifold alignment is rare 2025. It also builds on transformer‑based clocks that optimize multiple objectives but still treat omics as separate inputs Yang et al. 2025. The proposed mitochondrial coupling provides a biologically grounded regularizer that can be interpreted as a “pace‑maker” for multi‑omic aging.

Testable Predictions

1. Improved alignment – A multimodal variational autoencoder trained with the mitochondrial mutual‑information loss will show higher cross‑modality canonical correlation (average r >0.7) between held‑out omics layers than a baseline VAE without the loss (p<0.01, permutation test).

2. Better functional prediction – The mitochondrial‑aligned latent ΔAge will predict grip strength decline, gait speed, and cognitive test scores with higher effect size (Cohen’s d >0.6) than ΔAge from existing clocks (Klemera‑Doubal, PhenoAge, transformer baseline) in a cohort of >10 000 adults with longitudinal functional measures.

3. Specificity to mitochondrial perturbation – In a sub‑cohort treated with a mitochondrial booster (e.g., urolithin A) the mitochondrial‑aligned ΔAge will show a greater reduction relative to chronological age than clocks lacking the coupling term, indicating sensitivity to mitochondrial state.

4. Falsifiability – If the mitochondrial loss term does not increase cross‑modality correlation or functional prediction beyond chance, or if mitochondrial‑aligned ΔAge fails to distinguish mitochondrial intervention groups, the hypothesis is falsified.

Experimental Design

• Data: Use a public multi‑omics repository (e.g., NIH MOSAIC) with matched mitochondrial biomarkers (plasma citrate, succinate, cell‑free mtDNA) and functional outcomes.
• Model: Variational autoencoder with separate encoders for each omics layer, a shared latent space, and a decoder for each layer. Add a loss term L_mito = -I(Z; M) estimated via a contrastive predictor (MINE).
• Training: Optimize reconstruction + age alignment + mortality prediction + L_mito.
• Evaluation: Compare to baseline models using held‑out test set; compute statistical significance with bootstrapping.

If results confirm predictions, this work would establish mitochondrial retrograde signaling as a principled guide for true multi‑omic manifold alignment, addressing the open problem highlighted in recent literature.